Literature DB >> 21411527

Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

Tatsuya Ogawa1, Sachiyo Tsuji-Kawahara, Takae Yuasa, Saori Kinoshita, Tomomi Chikaishi, Shiki Takamura, Haruo Matsumura, Tsukasa Seya, Toshihiko Saga, Masaaki Miyazawa.   

Abstract

Natural killer (NK) cells function as early effector cells in the innate immune defense against viral infections and also participate in the regulation of normal and malignant hematopoiesis. NK cell activities have been associated with early clearance of viremia in experimental simian immunodeficiency virus and clinical human immunodeficiency virus type 1 (HIV-1) infections. We have previously shown that NK cells function as major cytotoxic effector cells in vaccine-induced immune protection against Friend virus (FV)-induced leukemia, and NK cell depletion totally abrogates the above protective immunity. However, how NK cells recognize retrovirus-infected cells remains largely unclear. The present study demonstrates a correlation between the expression of the products of retinoic acid early transcript-1 (RAE-1) genes in target cells and their susceptibility to killing by NK cells isolated from FV-infected animals. This killing was abrogated by antibodies blocking the NKG2D receptor in vitro. Further, the expression of RAE-1 proteins on erythroblast surfaces increased early after FV inoculation, and administration of an RAE-1-blocking antibody resulted in increased spleen infectious centers and exaggerated pathology, indicating that FV-infected erythroid cells are recognized by NK cells mainly through the NKG2D-RAE-1 interactions in vivo. Enhanced retroviral replication due to host gene-targeting resulted in markedly increased RAE-1 expression in the absence of massive erythroid cell proliferation, indicating a direct role of retroviral replication in RAE-1 upregulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411527      PMCID: PMC3094956          DOI: 10.1128/JVI.02146-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Friend erythroleukemia revisited.

Authors:  P A Ney; A D D'Andrea
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

Authors:  Amanda M Jamieson; Andreas Diefenbach; Christopher W McMahon; Na Xiong; James R Carlyle; David H Raulet
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

3.  Role of natural killer cells in resistance against friend retrovirus-induced leukemia.

Authors:  N Iwanami; A Niwa; Y Yasutomi; N Tabata; M Miyazawa
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2).

Authors:  H Arase; T Saito; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.

Authors:  U Dittmer; K E Peterson; R Messer; I M Stromnes; B Race; K J Hasenkrug
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.

Authors:  K E Peterson; M Iwashiro; K J Hasenkrug; B Chesebro
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage.

Authors:  T Kina; K Ikuta; E Takayama; K Wada; A S Majumdar; I L Weissman; Y Katsura
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

8.  Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.

Authors:  Ingunn M Stromnes; Ulf Dittmer; Ton N M Schumacher; Koen Schepers; Ronald J Messer; Leonard H Evans; Karin E Peterson; Brent Race; Kim J Hasenkrug
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.

Authors:  Karin E Peterson; Ingunn Stromnes; Ron Messer; Kim Hasenkrug; Bruce Chesebro
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

View more
  15 in total

1.  Elimination of friend retrovirus in the absence of CD8+ T cells.

Authors:  Sachiyo Tsuji-Kawahara; Masaaki Miyazawa
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

2.  A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.

Authors:  Gabriela Maria Wiedemann; Severin Johannes Jacobi; Michael Chaloupka; Angelina Krächan; Svetlana Hamm; Stefan Strobl; Roland Baumgartner; Simon Rothenfusser; Peter Duewell; Stefan Endres; Sebastian Kobold
Journal:  Oncoimmunology       Date:  2016-05-31       Impact factor: 8.110

3.  Differential requirements of cellular and humoral immune responses for Fv2-associated resistance to erythroleukemia and for regulation of retrovirus-induced myeloid leukemia development.

Authors:  Sachiyo Tsuji-Kawahara; Hiroyuki Kawabata; Hideaki Matsukuma; Saori Kinoshita; Tomomi Chikaishi; Mayumi Sakamoto; Yuri Kawasaki; Masaaki Miyazawa
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

4.  Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.

Authors:  Gail D Sckisel; Julia K Tietze; Anthony E Zamora; Hua-Hui Hsiao; Stephen O Priest; Danice E C Wilkins; Louis L Lanier; Bruce R Blazar; Nicole Baumgarth; William J Murphy
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

5.  Toll-like receptor 7 controls the anti-retroviral germinal center response.

Authors:  Edward P Browne
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

6.  Two genetic determinants acquired late in Mus evolution regulate the inclusion of exon 5, which alters mouse APOBEC3 translation efficiency.

Authors:  Jun Li; Yoshiyuki Hakata; Eri Takeda; Qingping Liu; Yasumasa Iwatani; Christine A Kozak; Masaaki Miyazawa
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

7.  Infection of adult thymus with murine retrovirus induces virus-specific central tolerance that prevents functional memory CD8+ T cell differentiation.

Authors:  Shiki Takamura; Eiji Kajiwara; Sachiyo Tsuji-Kawahara; Tomoko Masumoto; Makoto Fujisawa; Maiko Kato; Tomomi Chikaishi; Yuri Kawasaki; Saori Kinoshita; Manami Itoi; Nobuo Sakaguchi; Masaaki Miyazawa
Journal:  PLoS Pathog       Date:  2014-03-20       Impact factor: 6.823

8.  Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.

Authors:  Sam X Li; Bradley S Barrett; Karl J Heilman; Ronald J Messer; Rachel A Liberatore; Paul D Bieniasz; George Kassiotis; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2014-05-28       Impact factor: 5.422

9.  Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.

Authors:  Kathrin Gibbert; Jara J Joedicke; Andreas Meryk; Mirko Trilling; Sandra Francois; Janine Duppach; Anke Kraft; Karl S Lang; Ulf Dittmer
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

10.  Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection.

Authors:  Elisabeth Littwitz; Sandra Francois; Ulf Dittmer; Kathrin Gibbert
Journal:  Retrovirology       Date:  2013-11-01       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.